IR Biosciences Holdings Inc. Stock Other OTC
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 1.2M |
---|---|---|---|---|---|
Net income 2009 | -6M | Net income 2010 | -5M | EV / Sales 2009 | - |
Net Debt 2009 | 5.81M | Net Debt 2010 | 3.67M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 04-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 |
1st Jan change | Capi. | |
---|---|---|
+24.04% | 45.01B | |
+47.19% | 40.96B | |
-5.55% | 38.62B | |
+36.84% | 32.6B | |
-7.79% | 27.49B | |
+18.29% | 27.17B | |
+47.83% | 14.61B | |
+41.31% | 12.95B | |
-1.33% | 11.36B |